ARGX240517C340000
- 30.06
- 0.000.00%
argenx SE Newsroom
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading
European equities traded in the US as American depositary receipts were trending modestly higher late Friday morning, rising 0.29% to 1,426.43 on the S&P Europe Select ADR Index. The index is set to c
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were trending slightly higher Wednesday morning, rising 0.10% to 1,427.23 on the S&P Europe Select ADR Index. From continental Europe
Argenx SE: Strong Buy Rating on Vyvgart's Market Expansion and Promising Pipeline
Analysts Conflicted on These Healthcare Names: Guardant Health (GH), Argenx Se (ARGX) and Annexon Biosciences (ANNX)
Argenx Price Target Cut to $500.00/Share From $560.00 by JP Morgan
Argenx Price Target Cut to $500.00/Share From $560.00 by JP Morgan
Argenx Is Maintained at Overweight by JP Morgan
Argenx Is Maintained at Overweight by JP Morgan
Express News | JP Morgan Maintains Overweight on Argenx, Lowers Price Target to $500
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), ANI Pharmaceuticals (ANIP) and Argenx Se (ARGX)
Stifel Nicolaus Keeps Their Buy Rating on Argenx Se (ARGX)
Argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript
Argenx Price Target Cut to $448.00/Share From $451.00 by HC Wainwright & Co.
Argenx Price Target Cut to $448.00/Share From $451.00 by HC Wainwright & Co.
Argenx Is Maintained at Buy by HC Wainwright & Co.
Argenx Is Maintained at Buy by HC Wainwright & Co.
Breaking Down Argenx: 12 Analysts Share Their Views
In the latest quarter, 12 analysts provided ratings for argenx (NASDAQ:ARGX), showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their recent ratings, show
Argenx Is Maintained at Market Outperform by JMP Securities
Argenx Is Maintained at Market Outperform by JMP Securities
Express News | JMP Securities Maintains Market Outperform on Argenx, Lowers Price Target to $468
Argenx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 24.84% JMP Securities $471 → $468 Maintains Market Outperform 04/18/2024 38.97% Wedbush → $521
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%
European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.60 to 1,414.50 on the S&P Europe Select ADR Index. With the gain, the index is poi
Express News | Argenx SE : Evercore ISI Cuts Target Price to $437 From $444
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT) and Argenx Se (ARGX)
Buy Rating for Argenx Se Backed by Strong VYVGART Sales and Promising Pipeline Prospects